Clinical trial
Randomized Double-blind Controlled Clinical Trial: the Use of Mesoglycan vs Placebo in the Acute Phase of Hemorrhoidal Disease
NCT06101992 is registered in ClinicalTrials.gov with Societa Italiana di Chirurgia ColoRettale as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Double-blind Controlled Clinical Trial: the Use of Mesoglycan vs Placebo in the Acute Phase of Hemorrhoidal Disease
- Lead sponsor
- Societa Italiana di Chirurgia ColoRettale
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 1, 2024
- Completion date
- September 1, 2024
- Enrollment
- 50 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.